Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Bullinger

Showing results (31-40 of 80) with videos related to

Pageof 8
Sort By:
Leukemia|May 15, 2009
Thalidomide exerts distinct molecular antileukemic effects and combined thalidomide/fludarabine therapy is clinically effective in high-risk chronic lymphocytic leukemiaK Giannopoulos, A Dmoszynska, M Kowal, et al.
Leukemia|October 29, 2014
TGIF1 is a negative regulator of MLL-rearranged acute myeloid leukemiaA Willer, J S Jakobsen, E Ohlsson, et al.
Stereotactic and Functional Neurosurgery|October 14, 2024
Combination of or Transition between Deep Brain Stimulation and Responsive Neurostimulation for the Treatment of Drug-Resistant EpilepsyJimmy C Yang, Henry Skelton, Faical Isbaine, et al.
The American Journal of Managed Care|November 17, 2016
Evaluating dose ratio of subcutaneous to intravenous immunoglobulin therapy among patients with primary immunodeficiency disease switching to 20% subcutaneous immunoglobulin therapyGirishanthy Krishnarajah, Jee-Yeon K Lehmann, Brian Ellman, et al.
Leukemia|May 4, 2011
DNMT3A mutations in myeloproliferative neoplasmsF Stegelmann, L Bullinger, R F Schlenk, et al.
Leukemia|June 25, 2011
Deregulated apoptosis signaling in core-binding factor leukemia differentiates clinically relevant, molecular marker-independent subgroupsS C Lück, A C Russ, U Botzenhardt, et al.
Child Abuse & Neglect|July 25, 2024
A comparison of virtual versus in-person delivery of SafeCare on parent and implementation outcomesS Self-Brown, A Watson, K Fong, et al.
Leukemia|April 30, 2010
Gene expression profiling in AML with normal karyotype can predict mutations for molecular markers and allows novel insights into perturbed biological pathwaysA Kohlmann, L Bullinger, C Thiede, et al.
Neurosurgery|May 8, 2020
Letter: Evaluation and Surgical Treatment of Functional Neurosurgery Patients With Implanted Deep Brain Stimulation and Vagus Nerve Stimulation Pulse Generators During the COVID-19 PandemicRobert E Gross, Cathrin M Buetefisch, Svjetlana Miocinovic, et al.
ORL; Journal for Oto-Rhino-Laryngology and Its Related Specialties|February 24, 2017
Response Evaluation in Head and Neck Oncology: Definition and PredictionT K Hoffmann, P J Schuler, S Laban, et al.
Pageof 8

Showing results (31-40 of 80) with videos related to

Sort By:
Pageof 8
Leukemia|May 15, 2009
Thalidomide exerts distinct molecular antileukemic effects and combined thalidomide/fludarabine therapy is clinically effective in high-risk chronic lymphocytic leukemiaK Giannopoulos, A Dmoszynska, M Kowal, et al.
Leukemia|October 29, 2014
TGIF1 is a negative regulator of MLL-rearranged acute myeloid leukemiaA Willer, J S Jakobsen, E Ohlsson, et al.
Stereotactic and Functional Neurosurgery|October 14, 2024
Combination of or Transition between Deep Brain Stimulation and Responsive Neurostimulation for the Treatment of Drug-Resistant EpilepsyJimmy C Yang, Henry Skelton, Faical Isbaine, et al.
The American Journal of Managed Care|November 17, 2016
Evaluating dose ratio of subcutaneous to intravenous immunoglobulin therapy among patients with primary immunodeficiency disease switching to 20% subcutaneous immunoglobulin therapyGirishanthy Krishnarajah, Jee-Yeon K Lehmann, Brian Ellman, et al.
Leukemia|May 4, 2011
DNMT3A mutations in myeloproliferative neoplasmsF Stegelmann, L Bullinger, R F Schlenk, et al.
Leukemia|June 25, 2011
Deregulated apoptosis signaling in core-binding factor leukemia differentiates clinically relevant, molecular marker-independent subgroupsS C Lück, A C Russ, U Botzenhardt, et al.
Child Abuse & Neglect|July 25, 2024
A comparison of virtual versus in-person delivery of SafeCare on parent and implementation outcomesS Self-Brown, A Watson, K Fong, et al.
Leukemia|April 30, 2010
Gene expression profiling in AML with normal karyotype can predict mutations for molecular markers and allows novel insights into perturbed biological pathwaysA Kohlmann, L Bullinger, C Thiede, et al.
Neurosurgery|May 8, 2020
Letter: Evaluation and Surgical Treatment of Functional Neurosurgery Patients With Implanted Deep Brain Stimulation and Vagus Nerve Stimulation Pulse Generators During the COVID-19 PandemicRobert E Gross, Cathrin M Buetefisch, Svjetlana Miocinovic, et al.
ORL; Journal for Oto-Rhino-Laryngology and Its Related Specialties|February 24, 2017
Response Evaluation in Head and Neck Oncology: Definition and PredictionT K Hoffmann, P J Schuler, S Laban, et al.
Pageof 8